Achieving Self-Directed Integrated Cancer Aftercare (ASICA) in melanoma: protocol for a randomised patient-focused pilot trial of delivering the ASICA intervention as a means to earlier detection of recurrent and second primary melanoma

BACKGROUND: Melanoma is common; 15,906 people in the UK were diagnosed with melanoma in 2015 and incidence has increased fivefold in 30 years. Melanoma affects old and young people, with poor prognosis once metastatic. UK guidelines recommend people treated for cutaneous melanoma receive extended ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Murchie, P., Masthoff, J., Walter, F. M., Rahman, K., Allan, J. L., Burrows, N., Proby, C., Lee, A. J., Johnston, M., Durrani, A., Depasquale, I., Brant, B., Neilson, A., Meredith, F., Treweek, S., Hall, S., McDonald, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547590/
https://www.ncbi.nlm.nih.gov/pubmed/31159849
http://dx.doi.org/10.1186/s13063-019-3453-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547590/
https://www.ncbi.nlm.nih.gov/pubmed/31159849
http://dx.doi.org/10.1186/s13063-019-3453-x

Ejemplares similares